Columbia Contrarian Core-I3COFYX
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$34.72avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Columbia Contrarian Core-I3 (COFYX) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Coston, McIsaac & Partners ($50K).
- Company
- Columbia Contrarian Core-I3
- CUSIP
- 19766M709
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 2,441 shares sold, net −2,441 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Coston, McIsaac & Partners | 0.01% | Reduce -62.9% | 1,440 | $50K |
"% of holder's portfolio" is COFYX's weight in each manager's 13F, not the share of Columbia Contrarian Core-I3 the manager owns.